Approval of amended study protocol for the Phase 2a study in iMN
16 Sep 2022 //
PRESS RELEASE
SynAct announces outcome of rights issue
25 Apr 2022 //
CISION
SynAct Pharma Announces Positive Interim Phase 2 Data of AP1189
09 Nov 2020 //
PRNEWSWIRE